Literature DB >> 6189826

In vitro synthesis of laminin and entactin polypeptides.

M Kurkinen, D P Barlow, J R Jenkins, B L Hogan.   

Abstract

Total RNA and poly(A+) RNA, isolated from 13.5-day-old mouse embryo parietal endoderm cells and from differentiated F9 teratocarcinoma cells that synthesize laminin and entactin, were translated in the reticulocyte lysate. Antiserum raised against purified and denatured laminin B chains specifically immunoprecipitated from the translation reaction polypeptides of Mr = 205,000, 200,000, and 185,000. Antiserum against the native complex of laminin and entactin also immunoprecipitated these polypeptides, although less efficiently. In addition, this antiserum immunoprecipitated polypeptides of Mr = 300,000, 270,000, and 140,000. Antiserum against purified and denatured entactin immunoprecipitated only the Mr = 140,000 polypeptide. In contrast, no polypeptides were immunoprecipitated from translation reactions programmed with RNA from undifferentiated F9 cells that produce only small amounts of laminin and entactin. The in vitro synthesized polypeptides migrate on NaDodSO4-polyacrylamide gel electrophoresis slower than the respective unglycosylated laminin and entactin chains isolated from cells treated with tunicamycin. Supplementing the reticulocyte lysate with dog pancreas microsomal membranes yields in vitro translation products which co-migrate with the respective glycosylated laminin and entactin chains of control cells. Taken together, these results suggest that the polypeptides described represent in vitro synthesized laminin and entactin chains.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189826

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Development of Reichert's membrane in the early mouse embryo.

Authors:  M Salamat; N Miosge; R Herken
Journal:  Anat Embryol (Berl)       Date:  1995-09

2.  Differential regulation of viral and cellular genes in F9 mouse embryonal carcinoma cells.

Authors:  M J Sleigh
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

3.  Isolation of a cDNA clone for the human laminin-B1 chain and its gene localization.

Authors:  M Jaye; W S Modi; G A Ricca; R Mudd; I M Chiu; S J O'Brien; W N Drohan
Journal:  Am J Hum Genet       Date:  1987-10       Impact factor: 11.025

4.  Laminin biosynthesis in the extracellular matrix-producing cell line PFHR9 studied with monoclonal and polyclonal antibodies.

Authors:  J C Lissitzky; C Charpin; C Bignon; M Bouzon; F Kopp; P Delori; P M Martin
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

5.  Post-translational assembly and glycosylation of laminin subunits in parietal endoderm-like F9 cells.

Authors:  A Morita; E Sugimoto; Y Kitagawa
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

6.  Differential expression of laminin chains and receptor (LBP-32) in fetal and neoplastic hepatocytes compared to normal adult hepatocytes in vivo and in culture.

Authors:  P Y Rescan; B Clément; Y Yamada; B Segui-Real; G Baffet; C Guguen-Guillouzo; A Guillouzo
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

7.  Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide.

Authors:  M Nelson; D Nelson
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Linkage of genes for laminin B1 and B2 subunits on chromosome 1 in mouse.

Authors:  R W Elliott; D Barlow; B L Hogan
Journal:  In Vitro Cell Dev Biol       Date:  1985-08

9.  Isolation of cDNA clones for basal lamina components: type IV procollagen.

Authors:  M Kurkinen; D P Barlow; D M Helfman; J G Williams; B L Hogan
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

10.  Ultrastructural localization of carbohydrates in Reichert's membrane of the mouse.

Authors:  M Salamat; W Götz; A Horster; B Janotte; R Herken
Journal:  Cell Tissue Res       Date:  1993-05       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.